
Verge Genomics
Verge Genomics
Claim
Verge is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field's largest and most comprehensive databases of ALS (amyotrophic lateral sclerosis) and Parkinson's Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson's disease toward Show MoreVerge is focused on developing therapeutics for neurological diseases using human genomics to accele Show More
Alpha Score
$ 172.00 M
Alpha Score
71.2
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0